At close: December 20 at 5:29:32 PM GMT+1
Breakdown
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Assets
760,200.00
561,100.00
569,300.00
717,000.00
Total Liabilities Net Minority Interest
214,600.00
54,900.00
42,300.00
86,277.00
Total Equity Gross Minority Interest
545,600.00
506,200.00
527,000.00
630,723.00
Total Capitalization
649,000.00
506,200.00
527,000.00
630,723.00
Common Stock Equity
545,600.00
506,200.00
527,000.00
630,723.00
Capital Lease Obligations
4,400.00
2,700.00
4,200.00
4,667.00
Net Tangible Assets
136,400.00
95,900.00
115,700.00
218,334.00
Working Capital
242,000.00
98,000.00
113,700.00
229,730.00
Invested Capital
654,200.00
506,200.00
527,000.00
630,723.00
Tangible Book Value
136,400.00
95,900.00
115,700.00
218,334.00
Total Debt
113,000.00
2,700.00
4,200.00
4,667.00
Share Issued
292,571.46
214,589.13
179,906.41
179,906.41
Ordinary Shares Number
292,571.46
214,589.13
179,906.41
179,906.41
12/31/2020 - 4/7/2011
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
XBRANE.ST Xbrane Biopharma AB (publ)
0.1560
-4.29%
VICO.ST Vicore Pharma Holding AB (publ)
7.86
+2.75%
ISOFOL.ST Isofol Medical AB (publ)
2.4050
-3.80%
ONCO.ST Oncopeptides AB (publ)
1.5080
-1.69%
BIOVIC-B.ST Biovica International AB (publ)
1.7380
+8.63%
ACE.ST Ascelia Pharma AB (publ)
3.0000
-0.33%
HNSA.ST Hansa Biopharma AB (publ)
38.88
+6.11%
MVIR.ST Medivir AB (publ)
2.7600
-1.08%
AELIS.PA Aelis Farma SA
2.0800
0.00%
IRLAB-A.ST IRLAB Therapeutics AB (publ)
11.10
+1.83%